Access the comprehensive database of CRISPR and gene editing company domains. From Cas9 pioneers to next-generation base editors, discover verified websites of genome engineering companies revolutionizing genetic medicine.
Navigate the genome engineering landscape with comprehensive data on CRISPR developers and gene editing innovators.
CRISPR technology has revolutionized our ability to precisely edit genes, opening new frontiers in therapeutic development. Our database provides access to CRISPR-Cas9 companies, base editing developers, prime editing innovators, and epigenetic modification specialists.
Whether you're tracking FDA approval progress for CRISPR therapies, analyzing IP landscapes, or identifying licensing opportunities, our database delivers intelligence on companies developing precision gene editing tools for diverse applications.
"The gene editing market is projected to reach $15 billion by 2028, with CRISPR-based therapies achieving landmark approvals for sickle cell disease and beta-thalassemia." Our Gene Therapy Companies list offers complementary insights.
-- Gene Editing Market Analysis, 2024Comprehensive coverage of the genome engineering sector. Expand your research by viewing the Cell Therapy Developers section.
Classic gene knockout/knockin
Single nucleotide changes. Professionals often consult our Drug Discovery Companies data.
Search-and-replace editing
Gene regulation without cuts. Discover more in the Regenerative Medicine category.
LNP and AAV delivery
Crop improvement applications
Get instant access to 1,100+ gene editing company domains with comprehensive enrichment data. You may also be interested in our Clinical Stage Biotech dataset.
View Pricing Plans Back to Biotech & Biomedical